Endoscopic ultrasound-guided liver biopsy: a multicenter experience

David L Diehl, Amitpal S Johal, Harshit S Khara, Stavros N Stavropoulos, Mohammed Al-Haddad, Jayapal Ramesh, Shyam Varadarajulu, Harry Aslanian, Stuart R Gordon, Frederick K Shieh, Jonh J Pineda-Bonilla, Theresa Dunkelberger, Dibson D Gondim, Eric Z Chen, David L Diehl, Amitpal S Johal, Harshit S Khara, Stavros N Stavropoulos, Mohammed Al-Haddad, Jayapal Ramesh, Shyam Varadarajulu, Harry Aslanian, Stuart R Gordon, Frederick K Shieh, Jonh J Pineda-Bonilla, Theresa Dunkelberger, Dibson D Gondim, Eric Z Chen

Abstract

Background and aims: Endoscopic ultrasound-guided (EUS) liver biopsy (LB) is proposed as a newer method that offers several advantages over existing techniques for sampling liver tissue. This study evaluated the diagnostic yield of EUS-LB as the primary outcome measure. In addition, the safety of the technique in a large patient cohort was assessed.

Patients and methods: Patients undergoing EUS for evaluation of elevated liver enzymes or hepatic disease were included in this prospective, non-randomized, multicenter study. EUS-LB was performed with EUS-fine needle aspiration (FNA; 19-gauge needle). Tissue was formalin-fixed and stained with hematoxylin and eosin, and trichrome. Using a microscope micrometer, specimen length was measured and the number of complete portal triads (CPTs) were counted. The main outcome measure was to assess the diagnostic yield of EUS-LB, and to monitor for any procedure-related complications.

Results: Patients (110; median age, 53 years; 62 women) underwent EUS-LB at eight centers. The indication was abnormal liver enzymes in 96 patients. LB specimens sufficient for pathological diagnosis were obtained in 108 of 110 patients (98 %). The overall tissue yield from 110 patients was a median aggregate length of 38 mm (range, 0 - 203), with median of 14 CPTs (range, 0 - 68). There was no statistical difference in the yield between bilobar, left lobe only, or right lobe only biopsies. There was one complication (0.9 %) where self-limited bleeding occurred in a coagulopathic and thrombocytopenic patient. This complication was managed conservatively.

Conclusions: EUS-guided LB was a safe technique that yields tissue adequate for diagnosis among 98 % of patients evaluated.

Conflict of interest statement

Competing interests: None

Figures

Fig. 1
Fig. 1
EUS-LB using fine needle aspiration (19-gauge needle). a The left lobe of the liver. b The right lobe of the liver.
Fig. 2
Fig. 2
Tissue was expressed into the formalin container. a Visible core. b More bloody specimens; the contents of the container were poured into a petri dish. c The formalin-fixed pieces of liver tissue, distinguished from blood clot, were removed with forceps. d Next, the tissue was wrapped in lens paper and placed into a histology cassette for standard processing; the blood clot was also submitted. Usually, all material was processed in a single cassette.
Fig. 3
Fig. 3
Precise quantification of liver core lengths. a Digital measurements. b Representative photomicrographs showing liver tissue mixed with blood clot obtained from patients from this series. c Duodenal mucosa with right lobe EUS-LB; d Autoimmune hepatitis under high power view. e Steatohepatitis. f Non-caseating granulomatous hepatitis.

References

    1. Rockey D C, Caldwell S H, Goodman Z D. et al.AASLD Position Paper: Liver Biopsy. Hepatology. 2009;49:1017–1044.
    1. Kalambokis G, Manousou P, Vibhakorn S. et al.Transjugular liver biopsy - Indications, adequacy, quality of specimens, and complications - A systematic review. J Hepatol. 2007;47:284–294.
    1. Mathew A. EUS-guided liver biopsy in select patients. Am J Gastroenterol. 2007;102:2354–2355.
    1. Gleeson F C, Clayton A C, Zhang L. et al.Adequacy of endoscopic ultrasound core needle biopsy specimen of nonmalignant hepatic parenchymal disease. Clin Gastroenterol Hepatol. 2008;6:1437–1440.
    1. Dewitt J, McGreevy K, Cumming O. et al.Initial experience with EUS-guided Tru-cut biopsy of benign liver disease. Gastrointest Endosc. 2009;69:535–542.
    1. Stavropoulos S N, Im G Y, Jlayer Z. et al.High yield of same-session EUS-guided liver biopsy by 19-gauge FNA needle in patients undergoing EUS to exclude biliary obstruction. Gastrointest Endosc. 2012;75:310–318.
    1. Nakai Y, Samarasena J B, Iwashita T. et al.Autoimmune hepatitis diagnosed by endoscopic ultrasound-guided liver biopsy using a new 19-gauge histology needle. Endoscopy. 2012;44:E67–E68.
    1. Adler D G, Jacobson B C, Davila R E. et al.ASGE Guideline: complications of EUS. Gastrointest Endosc. 2005;61:8–12.
    1. Maharaj B, Maharaj R J, Leary W P. et al.Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet. 1986;1:523–525.
    1. Gor N, Salem S B, Jakate S. et al.Histological adequacy of EUS-guided liver biopsy when using a 19-gauge non-Tru-Cut FNA needle. Gastrointest Endosc. 2014;79:170–172.
    1. Musso G, Gambino E, Cassader M. et al.Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. 2011;43:617–649.

Source: PubMed

3
Suscribir